Correlation Between Canntab Therapeutics and Crescita Therapeutics
Can any of the company-specific risk be diversified away by investing in both Canntab Therapeutics and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Canntab Therapeutics and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Canntab Therapeutics Limited and Crescita Therapeutics, you can compare the effects of market volatilities on Canntab Therapeutics and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Canntab Therapeutics with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Canntab Therapeutics and Crescita Therapeutics.
Diversification Opportunities for Canntab Therapeutics and Crescita Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Canntab and Crescita is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Canntab Therapeutics Limited and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and Canntab Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Canntab Therapeutics Limited are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of Canntab Therapeutics i.e., Canntab Therapeutics and Crescita Therapeutics go up and down completely randomly.
Pair Corralation between Canntab Therapeutics and Crescita Therapeutics
Assuming the 90 days horizon Canntab Therapeutics is expected to generate 1.97 times less return on investment than Crescita Therapeutics. But when comparing it to its historical volatility, Canntab Therapeutics Limited is 1.76 times less risky than Crescita Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Crescita Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 56.00 in Crescita Therapeutics on November 2, 2024 and sell it today you would lose (17.00) from holding Crescita Therapeutics or give up 30.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.4% |
| Values | Daily Returns |
Canntab Therapeutics Limited vs. Crescita Therapeutics
Performance |
| Timeline |
| Canntab Therapeutics |
| Crescita Therapeutics |
Canntab Therapeutics and Crescita Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Canntab Therapeutics and Crescita Therapeutics
The main advantage of trading using opposite Canntab Therapeutics and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Canntab Therapeutics position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.| Canntab Therapeutics vs. Bionoid Pharma | Canntab Therapeutics vs. CTT Pharmaceutical Holdings | Canntab Therapeutics vs. Alterola Biotech | Canntab Therapeutics vs. HLS Therapeutics |
| Crescita Therapeutics vs. Amexdrug | Crescita Therapeutics vs. The BC Bud | Crescita Therapeutics vs. Cannara Biotech | Crescita Therapeutics vs. Knight Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |